Recombinant tissue plasminogen activator in the treatment of pleural infections in adults

Summary Background Intrapleural recombinant tissue plasminogen activator (r-TPA) has been successfully evaluated in pediatric patients with complicated parapneumonic pleural effusion (CPE) and pleural empyema (PE). Yet, there is no data concerning r-TPA in adults with CPE/PE. The aim of our study wa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiratory medicine 2008-12, Vol.102 (12), p.1694-1700
Hauptverfasser:	Froudarakis, Marios E, Kouliatsis, George, Steiropoulos, Paschalis, Anevlavis, Stavros, Pataka, Athanasia, Popidou, Maria, Mikroulis, Demitrios, Pneumatikos, Ioannis, Bouros, Demosthenes
Format:	Artikel
Sprache:	eng
Schlagworte:	Actilyse Adolescent Adult Aged Biological and medical sciences C-Reactive Protein - metabolism Chest Tubes Drainage Empyema Empyema, Pleural - diagnostic imaging Empyema, Pleural - drug therapy Empyema, Pleural - microbiology Female Fibrinolytics Humans Leukocyte Count Male Medical sciences Middle Aged Parapneumonic effusion Pleural Effusion - diagnostic imaging Pleural Effusion - drug therapy Pleural Effusion - microbiology Pleural infection Pneumology Pneumonia, Bacterial - complications Prospective Studies Pulmonary/Respiratory r-TPA Recombinant Proteins - adverse effects Recombinant Proteins - therapeutic use Tissue Plasminogen Activator - adverse effects Tissue Plasminogen Activator - therapeutic use Tomography, X-Ray Computed Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!